Market Place
Sourcing Support
NMPA Approves Chidamide+R-CHOP For Diffuse Large B-Cell Lymphoma
30 Apr 2024 //
PR NEWSWIRE
Clinical Results of ASC22 in Combination with Chidamide Presented at 12th IAS
24 Jul 2023 //
PR NEWSWIRE
SPHCC Completed 1st Patient Dosing in Study of PD-L1 Antibody ASC22 + Chidamide
04 Jul 2022 //
ASIAONE
SPHCC Initiated Study of Envafolimab + Chidamide in HIV
14 Feb 2022 //
PRNEWSWIRE
United BioPharma Received IND Approvals from Taiwan FDA and China NMPA
18 Aug 2021 //
PRESS RELEASE
NMPA Approves Chipscreen Bioscience`s Chidamide for Breast Cancer Indication
30 Nov 2019 //
PR NEWSWIRE
Chipscreen Announces a Collaboration with Innovent to Evaluate Chidamide
18 Feb 2019 //
PRNASIA
GNTbm announces licensing of exclusive sales rights of anticancer drug Chidamide
21 Jun 2018 //
PR NEWSWIRE
GNT Biotech, TPSC ink deal for anticancer drug Chidamide
21 Jun 2018 //
BIOSPECTRUM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.